These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18417173)

  • 21. Deletion of mu-opioid receptor in mice does not affect the minimum alveolar concentration of volatile anaesthetics and nitrous oxide-induced analgesia.
    Koyama T; Mayahara T; Wakamatsu T; Sora I; Fukuda K
    Br J Anaesth; 2009 Nov; 103(5):744-9. PubMed ID: 19767313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2.
    Mizoguchi H; Watanabe H; Hayashi T; Sakurada W; Sawai T; Fujimura T; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2006 Apr; 317(1):362-8. PubMed ID: 16394196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
    Schmauss C; Yaksh TL
    J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors.
    Valverde O; Ledent C; Beslot F; Parmentier M; Roques BP
    Eur J Neurosci; 2000 Feb; 12(2):533-9. PubMed ID: 10712632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors.
    Pacheco Dda F; Romero TR; Duarte ID
    Brain Res; 2014 May; 1562():69-75. PubMed ID: 24675031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse.
    Tseng LF; Narita M; Suganuma C; Mizoguchi H; Ohsawa M; Nagase H; Kampine JP
    J Pharmacol Exp Ther; 2000 Feb; 292(2):576-83. PubMed ID: 10640294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel κ-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation.
    Zhang LS; Wang J; Chen JC; Tao YM; Wang YH; Xu XJ; Chen J; Xu YG; Xi T; Hu XW; Wang YJ; Liu JG
    Acta Pharmacol Sin; 2015 May; 36(5):565-71. PubMed ID: 25816912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
    Zhao M; Wang JY; Jia H; Tang JS
    Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse.
    Jinsmaa Y; Fujita Y; Shiotani K; Miyazaki A; Li T; Tsuda Y; Okada Y; Ambo A; Sasaki Y; Bryant SD; Lazarus LH
    Eur J Pharmacol; 2005 Feb; 509(1):37-42. PubMed ID: 15713427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
    Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
    J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
    Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
    Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofilament proteins and cAMP pathway in brains of mu-, delta- or kappa-opioid receptor gene knock-out mice: effects of chronic morphine administration.
    García-Sevilla JA; Ferrer-Alcón M; Martín M; Kieffer BL; Maldonado R
    Neuropharmacology; 2004 Mar; 46(4):519-30. PubMed ID: 14975676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement.
    Negus SS; Mello NK
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1132-40. PubMed ID: 10454487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of divalent cations on the analgesic effect of opioid and non-opioid drugs.
    Assi AA
    Pharmacol Res; 2001 Jun; 43(6):521-9. PubMed ID: 11419960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.
    Aley KO; Levine JD
    J Neurosci; 1997 Jan; 17(2):735-44. PubMed ID: 8987795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
    Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvements of mu- and kappa-opioid receptors in morphine-induced antinociception in the nucleus accumbens of rats.
    Xiong W; Yu LC
    Neurosci Lett; 2006 May; 399(1-2):167-70. PubMed ID: 16490317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability.
    Yi SP; Kong QH; Li YL; Pan CL; Yu J; Cui BQ; Wang YF; Wang GL; Zhou PL; Wang LL; Gong ZH; Su RB; Shen YH; Yu G; Chang KJ
    Acta Pharmacol Sin; 2017 Jul; 38(7):977-989. PubMed ID: 28502978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.